Effects of omeprazole and cimetidine on the urinary metabolic ratio of proguanil in healthy volunteers

European Journal of Clinical Pharmacology

Volumn 50, Issue 5, 1996, Pages 417-419

  Somogyi, A A ^a   Reinhard, H A ^a   Bochner, F ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Cimetidine; CYP2C19; Drug interaction; Metabolic ratio; Omeprazole; Proguanil

Indexed keywords

CIMETIDINE; CYCLOGUANIL; CYTOCHROME P450; DRUG METABOLITE; OMEPRAZOLE; PROGUANIL;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EXCRETION; DRUG INTERACTION; DRUG METABOLISM; DRUG URINE LEVEL; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PRIORITY JOURNAL; VOLUNTEER;

ADULT; ARYL HYDROCARBON HYDROXYLASES; CHLOROGUANIDE; CIMETIDINE; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INHIBITORS; FEMALE; HUMANS; MALE; MIXED FUNCTION OXYGENASES; OMEPRAZOLE; TRIAZINES;

EID: 0029953919     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050133     Document Type: Article

References (18)

1. Andersson T, Andren K, Cederberg C, Edvardsson G, Heggelund A, Lundborg P (1990a) Effect of omeprazole and cimetidine on plasma diazepam levels. Eur J Clin Pharmacol 39:51-54
2. Andersson T, Cederberg C, Edvardsson G, Heggelund A, Lundborg P (1990b) Effect of omeprazole treatment on diazepam plasma levels in slow versus normal rapid metabolizers of omeprazole. Clin Pharmacol Ther 47:79-85
3. Andersson T, Miners JO, Veronese ME, Birkett DJ (1994) Diazepam metabolism by human liver microsomes is mediated by both S-mephenytoin hydroxylase and CYP3A isoforms. Br J Clin Pharmacol 38:131-137
4. Andersson T, Miners JO, Veronese M, Tassaneeyakul W, Tassaneeyakul W, Meyer U, Birkett DJ (1993) Identification of human liver cytochrome P450 isoforms mediating omeprazole metabolism. Br J Clin Pharmacol 36:521-530
5. Andersson T, Regårdh C-G, Lou Y-C, Zhang Y, Dahl M-L, Bertilsson L (1992) Polymorphic hydroxylation of S-mephenytoin and omeprazole metabolism in caucasian and chinese subjects. Pharmacogenetics 2:25-31
6. Birkett DJ, Rees D, Andersson T, Gonzalez FJ, Miners JO, Veronese ME (1994) In vitro proguanil activation to cycloguanil by human liver microsomes is mediated by CYP3A isoforms as well as by S-mephenytoin hydroxylase. Br J Clin Pharmacol 37:413-420
7. Chiba K, Kobayashi K, Manabe K, Tani M, Kamataki T, Ishizaki T (1993) Oxidative metabolism of omeprazole in human liver microsomes: co-segregation with S-mephenytoin 4′-hydroxylation. J Pharmacol Exp Ther 266:52-59
8. Funck-Brentano C, Bosco O, Jacqz-Aigrain E, Keundjian A, Jaillon P (1992) Relation between chloroguanide bioactivation to cycloguanil and the genetically determined metabolism of mephenytoin in humans. Clin Pharmacol Ther 51:507-512
9. Gugler R and Jensen CJ (1985) Omeprazole inhibits oxidative drug metabolism: studies with diazepam and phenytoin in vivo and 7-ethoxycoumarin in vitro. Gastroenterology 89:1235-1241
10. Helsby NA, Ward SA, Edwards G, Howells RE, Breckenridge AM (1990) The pharmacokinetics and activation of proguanil in man: consequences of variability in drug metabolism. Br J Clin Pharmacol 30:593-598
11. Klotz U and Reimann I (1980) Delayed clearance of diazepam due to cimetidine. N Engl J Med 302:1012-1014
12. Sohn DR, Kobayashi K, Chiba K, Lee KH, Shin SG, Ishizaki T (1992) Disposition kinetics and metabolism of omeprazole in extensive and poor metabolizers of S-mephenytoin 4′-hydroxylation recruited from an oriental population. J Pharmacol Exp Ther 262:1195-1202
13. Somogyi A, Muirhead M (1987) Pharmacokinetic interaction of cimetidine 1987. Clin Pharmacokinet 12:321-366
14. Somogyi AA, Bochner F, Sallustio BC (1992) Stereoselective inhibition of pindolol renal clearance by cimetidine in humans. Clin Pharmacol Ther 51:379-387
15. Somogyi A, Reinhard H, Bochner F (1994) Disposition of proguanil in poor and extensive metabolisers. Can J Physiol Pharmacol 72 (suppl 1):305
16. Taylor RB, Moody RR, Ochekpe NA (1987) Determination of proguanil and its metabolites cycloguanil and 4-chlorophenylbiguanide in plasma, whole blood and urine by high-performance liquid chromatography. J Chromatogr 416:394-399
17. Ward SA, Helsby NA, Skjelbo E, Brosen K, Gram LF, Breckenridge AM (1991) The activation of the biguanide antimalarial proguanil co-segregates with the mephenytoin oxidation polymorphism - a panel study. Br J Clin Pharmacol 31: 689-692
18. Wattanagoon Y, Taylor RB, Moody RR, Ochekpe NA, Looareesuwan S, White NJ (1987) Single dose pharmacokinetics of proguanil and its metabolites in healthy subjects. Br J Clin Pharmacol 24:775-780